ghk-cu maximum daily dose Copper Peptide (GHK-Cu): Clinical Uses, Stability & Compounding Tips GHK-Cu Nasal Spray 50mg |

Miami Injections | Medical Weight Loss Clinic in Miami

The pending EVOKE and EVOKE Plus trials of daily oral semaglutide participants aged 5585 years with mild cognitive impairment or mild dementia due to Alzheimers disease with confirmed amyloid abnormalities by PET scan or cerebrospinal fluid biomarkers The only difference in the 2 trials is with respect to entry criteria with EVOKE Plus that allows for small vessel pathology

In cardiovascular care, vitamin B12 helps regulate homocysteine levels, reducing risks associated with heart disease and stroke

A scoping review in Cureus (2025) added important context: dual-acting agonists like tirzepatide which targets both GLP-1 and GIP receptors produced greater reductions in weight and insulin sensitivity than GLP-1-only agents

Unlike some treatments that plateau quickly, microneedling appears to continue producing improvements with sustained use